Home NDC 72205-170
Acyclovir suspension
Product NDC 72205-170
11-digit product format 722050170
Labeler code 72205
Product ID 72205-170_3efa1e5e-5a14-4724-a2ca-25702f10faed
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form SUSPENSION
Route ORAL
Labeler Novadoz Pharmaceuticals LLC
Application ANDA217393
Marketing category ANDA
Marketing start 2023-03-09
Substance ACYCLOVIR
Active strength 200 mg/5mL
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Acyclovir suspension
Listing expiration 2026-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 200 mg/5mL
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 307730
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72205-170-72 Acyclovir suspension 473 mL in 1 BOTTLE SUSPENSION 473 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72205-170 ACYCLOVIR SUSPENSION (ACYCLOVIR) SUSPENSION [NOVADOZ PHARMACEUTICALS LLC] 1 Current NDC, 1 package rows 20231111_3efa1e5e-5a14-4724-a2ca-25702f10faed.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72205-170-72 72205017072 473 mL in 1 BOTTLE (72205-170-72) 473 ml 2023-10-23 No No Current